Jonathan Paul Piccini, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member in the Duke Clinical Research Institute
Campus mail Dept of Medicine, Durham, NC 27710
Phone (919) 684-8111
Email address jonathan.piccini@duke.edu

Jonathan P. Piccini, MD, MHS is a clinical cardiac electrophysiologist and Associate Professor of Medicine at Duke University Medical Center and the Duke Clinical Research Institute. His research interests include the conduct of clinical trials and the assessment of cardiovascular therapeutics for the care of patients with heart rhythm disorders. At present, he is the Director of the EP Clinical Trials Program and Arrhythmia Core Laboratory at Duke University. He also serves on the Clinical Working Group of the American Heart Association’s Get With The Guidelines – Atrial fibrillation (GWTG-Afib) registry program. He is an associate editor for the American Heart Journal and serves on the editorial board of Heart Rhythm, the European Heart Journal, and the Journal of Cardiac Electrophysiology. He is the Principal Investigator of the data and coordinating center for ORBIT AF, a 25,000 patient registry focused on quality of care and improving outcomes in patients with atrial fibrillation. He is also the PI of the GENETIC AF clinical trial, the first clinical trial to study genotype-directed rhythm control therapy for atrial fibrillation. He also serves on the steering committees of multiple international randomized trials focused on the treatment of atrial fibrillation.  Dr. Piccini has more than 175 publications in the field of heart rhythm medicine. Clinically, his focus is on the care of patients with atrial fibrillation and complex arrhythmias, with particular emphasis on catheter ablation and lead extraction.

Education and Training

  • Clinical Cardiac Electrophysiology Fellowship, Medicine, Duke University School of Medicine, 2009 - 2011
  • Cardiology Fellowship, Medicine, Duke University School of Medicine, 2005 - 2009
  • Internal Medicine Residency, Medicine, Johns Hopkins University School of Medicine, 2002 - 2005
  • M.H.S., Duke University, 2009
  • M.D., Northwestern University Feinberg School of Medicine, 2002

Publications

Black-Maier, Eric, Robert K. Lewis, Adam S. Barnett, Sean D. Pokorney, Albert Y. Sun, Jason I. Koontz, James P. Daubert, and Jonathan P. Piccini. “Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with left ventricular assist devices: a case series and systematic review.” Heart Rhythm, April 15, 2020. https://doi.org/10.1016/j.hrthm.2020.04.019.

PMID
32304733
Full Text

Black-Maier, Eric, Robert K. Lewis, Michael Rehorn, Rahul Loungani, Daniel J. Friedman, Camille Frazier-Mills, Kevin P. Jackson, et al. “Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.” J Cardiovasc Electrophysiol, April 10, 2020. https://doi.org/10.1111/jce.14487.

PMID
32275340
Full Text

Friedman, Daniel J., Jeffrey G. Gaca, Tongrong Wang, S Chris Malaisrie, David R. Holmes, Jonathan P. Piccini, Rakesh M. Suri, et al. “Use of left atrial appendage occlusion among older cardiac surgery patients with preoperative atrial fibrillation: a national cohort study.” J Interv Card Electrophysiol 57, no. 3 (April 2020): 399–407. https://doi.org/10.1007/s10840-019-00519-w.

PMID
30712076
Full Text

Liu, Peter R., Daniel J. Friedman, Adam S. Barnett, Kevin P. Jackson, James P. Daubert, and Jonathan P. Piccini. “Focal impulse and rotor modulation of atrial rotors during atrial fibrillation leads to organization of left atrial activation as reflected by waveform morphology recurrence quantification analysis and organizational index.” J Arrhythm 36, no. 2 (April 2020): 311–18. https://doi.org/10.1002/joa3.12311.

PMID
32256880
Full Text

Pokorney, Sean D., Eric Black-Maier, Anne S. Hellkamp, Daniel J. Friedman, Sreekanth Vemulapalli, Christopher B. Granger, Laine Thomas, Eric D. Peterson, and Jonathan P. Piccini. “Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.” J Am Coll Cardiol 75, no. 11 (March 24, 2020): 1299–1308. https://doi.org/10.1016/j.jacc.2020.01.019.

PMID
32192656
Full Text

Friedman, Daniel J., Jed A. Overmann, Jeffrey M. Fish, Stephen A. Gaeta, John H. Tranter, Riki Thao, and Jonathan P. Piccini. “Impact of interruptions in radiofrequency energy delivery on lesion characteristics.” Heart Rhythm, March 19, 2020. https://doi.org/10.1016/j.hrthm.2020.03.008.

PMID
32200047
Full Text

Kloosterman, Mariëlle, Winnie Chua, Larissa Fabritz, Hussein R. Al-Khalidi, Ulrich Schotten, Jens C. Nielsen, Jonathan P. Piccini, et al. “Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5.” Europace, March 6, 2020. https://doi.org/10.1093/europace/euaa015.

PMID
32142113
Full Text

Steinberg, Benjamin A., Jeffrey Turner, Ann Lyons, Joshua Biber, Mihail G. Chelu, James C. Fang, Roger A. Freedman, et al. “Systematic collection of patient-reported outcomes in atrial fibrillation: feasibility and initial results of the Utah mEVAL AF programme.” Europace 22, no. 3 (March 1, 2020): 368–74. https://doi.org/10.1093/europace/euz293.

PMID
31702780
Full Text

Zeitler, Emily P., Daniel J. Friedman, Zak Loring, Kristen B. Campbell, Sarah A. Goldstein, Zachary K. Wegermann, Jane Schutz, et al. “Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.” Heart Rhythm 17, no. 3 (March 2020): 447–54. https://doi.org/10.1016/j.hrthm.2019.09.024.

PMID
31561032
Full Text

Pages